Nathan J Dowden Entrada Therapeutics, Inc. (TRDA) insider trading activity
Nathan J Dowden is President & COO of Entrada Therapeutics, Inc.. Currently has a direct ownership of 125,149 shares of TRDA, which is worth approximately $2.2 Million. The most recent transaction as insider was on Oct 20, 2022, when has been sold 905 shares (Common Stock) at a price of $18.07 per share, resulting in proceeds of $16,353. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
125K
0.67%
3M change
159.82%
12M change
Total Value Held
$2.2 Million
Nathan J Dowden Transaction History
NJD
Nathan J Dowden
President & COO
Boston, MA